taiba pharma group Sets Up New Manufacturing Company “MENAGENE”
taiba Healthcare Group announces setting up “MENAGENE PHARMACEUTICAL INDUSTRIES” for developing and manufacturing innovative specialty products in the Middle East/North Africa region.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180604005774/en/
Our New Manufacturing Facility In Oman (Photo: AETOSWire)
MENAGENE is located in Muscat, Oman (part of GCC countries) and is expected to be operational in the beginning of 2020. It will acquire market authorization rights for the MENA region and provide high quality products and services to all customers and stakeholders in the Middle East. taiba strategic plan consists of an investment on MENAGENE of approx. $50 million and this new strategy strengthens taiba group position in addressing the needs of the Middle East market.
The CEO of taiba group, Dr Saif Al Hasani is strongly committed to bringing access for patients to innovative treatments and cover the high unmet patient needs in the MENA region. He highlights that the key success factors of the company are its cooperation with reputable international partners, its investment on high caliber people, the deep understanding of the specialty and rare disease products and the culture of the stakeholders in the Middle East. taiba commits to invest the needed resources to maximize impact and benefit to patients in the region.
taiba group is a leading healthcare company focusing on niche therapeutic segments including rare diseases and orphan products in the MENA region. taiba has regional HQ in Dubai and logistics hubs in GCC countries and reaches all of the MENA region. taiba is privately held with 130 employees and has had a robust annual growth for over 5 consecutive years with annual sales of $150 million in 2017. taiba’s leading international partners include Alexion, Biomarin, Vertex, Aegerion, Veloxis, etc. and is well known in the therapeutic areas of Hematology/Oncology, Genetics/Metabolics, Transplantation and other Specialty orphan diseases. taiba is able to adapt its business model according to the needs of the partners and in fulfilling the needs of the market.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Scanlog Strengthens its Position at the Cutting Edge of Logistics Innovation by Embracing Robotic Process Automation from Softomotive15.10.2018 12:08 | Pressemelding
Scandinavian Logistics Partners AB (Scanlog), a rapidly expanding Scandinavian logistics company specializing in international transports, is using ProcessRobot from Softomotive to help transform its order booking process and develop a smarter workflow. ProcessRobot is a leading enterprise Robotic Process Automation (RPA) platform, including enterprise grade security and controls, with links to best-of-breed AI technologies. With ProcessRobot handling increasing numbers of customer orders, Scanlog has fortified its position as a technology leader in the logistics sector, and can deliver a speedier shipping service for its clients. Mattias Ljungberg , CEO of Scanlog, explains: “With ProcessRobot, we have reduced the time it takes to process each customer order by 89 percent. Previously it took a human employee up to four minutes to enter the booking details to our systems: now, the robot completes the task within 20 seconds.” Scanlog has ambitious plans to automate many other processes
MAXON Announces Senior Leadership Appointments15.10.2018 12:00 | Pressemelding
MAXON, the leading developer of professional 3D software solutions, today announced leadership appointments to make it a globally-focused software development company. The executive leadership team changes, effective immediately, reflect the strategic goals of David McGavran, Chief Executive Officer, for the future of MAXON and its acclaimed 3D software application, Cinema 4D. “This is an exciting and transformational time in the evolution of MAXON and I’m eager to work with our new leadership team that represents the very best talent across our offices poised to take MAXON to the next level,” stated McGavran. “With proven track records of delivering strong results, I am pleased to have these talented and passionate executives join me in streamlining operational initiatives to best serve global customers and partners, anticipate the ever-changing needs of the 3D digital landscape, and maintain Cinema 4D’s standing as a best-in-class market leader in 3D content creation.” Executive Team
PotNetwork Holdings, Inc. Files Form 10 To Become SEC Reporting Company15.10.2018 12:00 | Pressemelding
PotNetwork Holdings, Inc. (OTC Pink: POTN) announced today that it has filed a Registration Statement on Form 10 with the U.S. Securities and Exchange Commission (SEC) to register its common stock under the Securities Exchange Act of 1934, as amended (the Act) including its audited financial statements for the year ended December 31, 2017 and unaudited interim financial statements through June 30, 2018. POTN had engaged PCAOB member firm Manohar, Chowdhry & Associates, in July 2017 to replace its former auditor. The Company’s voluntary filing of the Form 10 will make the Company subject to the periodic reporting requirements of the Act which includes annual, quarterly and current report filings. Additionally, the filing will enable the Company’s management to move forward with its application to OTC Markets to uplist to the OTCQB market tier. As a result of investor feedback and management’s plan for a new, broadened strategic direction, the Company has rescinded the previously announc
Scientist.com’s Online Compliance Solution (COMPLi™) Wins Prestigious CPhl Pharma Award15.10.2018 11:55 | Pressemelding
Scientist.com is pleased to announce its online compliance solution COMPLi™ was recognized as the winner of the prestigious Regulatory Procedures and Compliance award at the 2018 CPhl Pharma Awards held in Madrid, Spain on October 9, 2018. COMPLi™ is a first-of-its-kind solution that allows pharmaceutical and biotech companies to confidently outsource regulated services such as human biological sample (HBS) acquisition, secondary real-world evidence (RWE), health economics and outcomes research (HEOR) and GxP services. “COMPLi™ enables research organizations to address the biggest challenges they face when sourcing regulated services: transparency, visibility and control,” stated Matt McLoughlin, VP of Compliance at Scientist.com. “COMPLi™ addresses compliance and governance requirements at every critical step of the sourcing process to speed up drug research and reduce the associated risks of outsourcing.” By simplifying and standardizing processes that previously took months, COMPLi™
DEWA Organises 20th WETEX & 3rd Dubai Solar Show from 23-25 October 201815.10.2018 10:58 | Pressemelding
In a press conference held in Dubai, HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA), announced details of the 20th Water, Energy, Technology, and Environment Exhibition (WETEX 2018) and the 3rd Dubai Solar Show. DEWA organises the two exhibitions at the Dubai International Convention and Exhibition Centre from 23 to 25 October 2018. WETEX 2018, under the theme ‘At the forefront of sustainability,’ will be the biggest in the exhibition’s history, covering 78,413 square metres. It will host 2,100 exhibitors from 53 countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181015005457/en/ DEWA organises 20th WETEX & 3rd Dubai Solar Show from 23-25 October 2018 (Photo: AETOSWire) WETEX is the largest of its kind in the region and one of the biggest specialised exhibitions in the world. It has become an annual event for regional and international companies in the energy, water, clean energy,
Bank of America Reports Third-Quarter 2018 Financial Results15.10.2018 10:54 | Pressemelding
Bank of America reported its third-quarter 2018 financial results today. The news release, supplemental filing and investor presentation can be accessed in the following ways: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181015005455/en/ Bank of America newsroom at https://newsroom.bankofamerica.com Bank of America Investor Relations website at http://investor.bankofamerica.com Business Wire’s news webpage at http://www.businesswire.com/portal/site/home/news Investor Conference Call information Chief Executive Officer Brian Moynihan and Chief Financial Officer Paul Donofrio will discuss the financial results in a conference call at 8:30 a.m. ET today. For a listen-only connection to the conference call, dial 1.877.200.4456 (U.S.) or 1.785.424.1732 (international), and the conference ID is 79795. Please dial in 10 minutes prior to the start of the call. Investors can also listen to a live audio webcast of the conference cal